Indian Journal of Medical Research

: 2019  |  Volume : 150  |  Issue : 5  |  Page : 432--435

Waterborne & foodborne viral hepatitis: A public health perspective

Abhik Sinha1, Shanta Dutta2,  
1 Department of Clinical Medicine, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700 055, West Bengal, India
2 Department of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700 055, West Bengal, India

Correspondence Address:
Abhik Sinha
Department of Clinical Medicine, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700 055, West Bengal

How to cite this article:
Sinha A, Dutta S. Waterborne & foodborne viral hepatitis: A public health perspective.Indian J Med Res 2019;150:432-435

How to cite this URL:
Sinha A, Dutta S. Waterborne & foodborne viral hepatitis: A public health perspective. Indian J Med Res [serial online] 2019 [cited 2020 Sep 29 ];150:432-435
Available from:

Full Text

Viral hepatitis is a hepatic disorder of public health importance. and it can be waterborne/foodborne or bloodborne[1]. Waterborne or foodborne hepatitis caused by hepatitis A virus (HAV) and hepatitis E virus (HEV), has faeco-oral route of transmission[2]. The World Health Organization (WHO) report reveals that viral hepatitis presently ranks as the 7th leading cause of mortality worldwide[2]. Normally, both HAV and HEV may cause outbreaks or present in epidemic form, and the disease is usually self-limiting[2].

Understanding the epidemiology and biological determinants of hepatitis A and E is very important. HAV belongs to the family Picornaviridae and genus Hepatovirus. Based on their genetic diversities, HAVs are divided into six lineage or genotypes; of those, genotypes 1, 2 and 3 infect human beings. HEV genotype 1 affects mainly young adults including women of reproductive age. Unique characteristics of HEV genotype 1 cause high mortality among pregnant women[1]. Studies across the globe have revealed that HEV genotype 1 is endemic in Asia and Africa, and HEV genotype 3 is the main cause of disease in the developed countries[1],[3]. In India, HAV genotypes 1 and 3 and HEV genotype 1 are the predominant strains. An upward shift in the average age for contracting first HAV infection has been observed among the socioeconomically developed Indian population resulting in pockets of susceptible population[1],[3], low seroprevalence has been reported until the age of 15 yr, reaching to 40 per cent in young adults[3]. HEV is more common among the children in India. It is a major public health threat during pregnancy causing acute liver failure[4]. Mortality in general population ranges from 0.1 to 4 per cent, while among women in the third trimester of pregnancy, it can reach up to 25 per cent[5]. HEV may be responsible for 10-40 per cent of acute hepatitis and 15-45 per cent of liver failure in India[6]. Seroprevalence of HAV and HEV has been studied across the globe, and socio-economic status, age and source of drinking water have been found to be the major determinants for seroprevalence of HAV and HEV[7].

Average incubation period of HAV is 30 days with a range being 15-50 days[1]. Clinical presentation of HAV infection may be asymptomatic (anicteric) or icteric[1]. The common presentation of HAV infection is jaundice and reduction in appetite. Anicteric clinical presentation with increased level of aminotransferase may occur. Other associated symptoms of HAV infection are anorexia, malaise, fatigue, fever, myalgia, arthralgia, headache, abdominal pain, etc. Infection due to HAV usually recovers on its own, but there may be relapse of the symptoms after 12-18 months. HAV-related infections may become fulminant if not managed properly. The risk factors associated with occurrence of fulminant HAV hepatitis are alcoholism, malnutrition, chronic liver disease and prolonged use of acetaminophen[1],[8].

Incubation period following exposure to HEV ranges from 2 to 10 wk with an average of 5-6 wk[4]. The infected persons are believed to shed the virus beginning a few days before to around 3-4 wk after the onset of the disease. In areas with disease endemicity, symptomatic infection is common in young adults aged between 15 and 40 yr[4],[9]. Pregnant women with HEV particularly those in the second and third trimester are at the risk of acute liver failure and foetal loss[10]. Chronic HEV infection is not common, but it can occur in immunosuppressed people particularly organ transplant recipients on immunosuppressive drugs with genotypes 3 and 4[4].

HEV is unique because it has several susceptible animal species capable of functioning as a reservoir of the disease (swine, wild boar and deer). Zoonotic transmission caused by genotypes 3 and 4 has been seen[11],[12]. Zoonotic transmission through direct contacts with infected animals has also been reported. Farmers, veterinarians and workers attending animals often comprise the at-risk group for HEV infection[13],[14],[15].

Vertical transmission of HEV has also been demonstrated via intrauterine and perinatal routes[16],[17],[18],[19]. The clinical course in vertically transmitted hepatitis E survivor neonates is self-limiting[17]. Comparative molecular analysis of HEV sequences from blood donors and recipients has been performed, and direct evidence of parenteral transmission (HEV genotypes 1 and 3) has been reported[20],[21].

The most reported source of foodborne hepatitis A outbreaks has been HAV-infected food handlers present at the point of sale (such as in a restaurant) or who prepare food for social events (such as a wedding). A single HAV-infected food handler can transmit HAV to dozens or even hundreds of persons and cause a substantial economic burden to public health[22],[23]. Hepatitis A outbreaks have also been found to be associated with consumption of freshly produced vegetables and fruits contaminated with HAV during cultivation, harvesting, processing or distribution[24].

Definitive diagnosis of HEV is based on the detection of the specific IgM antibody to the virus in the patient's blood, and this is usually adequate in areas where the disease is endemic[2],[4]. Additional test includes reverse transcription polymerase chain reaction (RT-PCR) to detect the HEV RNA in clinical samples like blood/stool. This assay requires specialized laboratory facilities and is particularly needed in the areas where HEV is infrequent or for the cases with chronic HEV infection[4],[9]. Several diagnostic flow charts have been proposed, but the standardization of diagnostic criteria still remains critical[25]. Diagnosis of HEV infection in immunocompromised patients and solid organ transplant recipients in whom seroconversion to anti-HEV antibodies is delayed or may not occur at all, is often challenging.

The treatment of HEV in normal course is supportive as the disease is self-limiting. Hospitalization is required for patients presented with fulminant hepatitis and symptomatic pregnant women. Immunosuppressed people with chronic HEV infection benefit from specific treatment with ribavirin, and in some specific situation, interferon has been successfully used[4].

Whether HAV and HEV vaccines are to be introduced in the Universal Immunization Programme is an important area of research to be addressed[26]. Mixing of contaminated sewage water with drinking water sources during natural disasters imposes a major public health threat. During such natural disasters, ingestion of contaminated water (by sewage/or inadequately treated) is an important source of infection of HAV and HEV[26]. The largest risk of foodborne HEV is introduction through food into regions where population herd immunity is relatively limited. Epidemiological studies have provided evidence for consumption of undercooked or raw meat as risk factor for acquisition of HEV infection[4],[27],[28].

In China, studies have revealed that the seroprevalence of HEV is generally low among children, and it increases with age. In males, the increase with age was most marked in 15-29 yr olds, and in females, this occurred in 20-39 yr olds[29]. Individuals living in the southern part of China had higher regional seroprevalence estimates than in those living in North China[29]. Among the different economic development areas, individuals living in Western China had the highest regional seroprevalence estimates[29]. Individuals in the age group of 15-60 yr and those living in Western China showed significantly higher odds of HEV seropositivity[29] compared to other parts of China[29]. A study conducted in rural Bangladesh found that the seroprevalence of hepatitis E was 22.5 per cent[30]. The seroprevalence of hepatitis E among urban and rural populations in Vellore, India was found to be 14.48 per cent[31]. In a multicentric study among healthy volunteers (the army recruits), the seroprevalence of hepatitis E was found to be 17.05 per cent and that of hepatitis A was 92.68 per cent[32].

The mortality due to communicable disease has declined globally, but absolute burden and relative ranking of viral hepatitis as a cause of mortality has increased from 1990 to 2013[2]. Thus, the plan of the Government of India was to eliminate viral hepatitis as a major public health threat in the region by the year 2030[33]. This plan includes elimination of both bloodborne and waterborne forms of viral hepatitis. The WHO has asked each of the Member States to prepare a National Action Plan to combat against viral hepatitis[33].

The National Viral Hepatitis Control Programme was launched by the Government of India in July 2018[33]. Lack of awareness among public healthcare providers, asymptomatic infection during early stages and lack of proper diagnostic facilities at all levels are the major challenges for control of viral hepatitis in India. The prevention of mortality for waterborne viral hepatitis includes prevention of new infections, management of viral hepatitis including diagnosis and treatment programme, capacity building at various levels and effective surveillance system[33].

Vaccines are available both for HAV and HEV. Hepatitis A vaccine is used in India. Hepatitis E vaccine was licensed in China in 2011[33]. WHO's Strategic Advisory Group of Experts on Immunization reviewed the existing evidence on the safety, immunogenicity, efficacy and cost-effectiveness of the licensed hepatitis E vaccine[2],[33]. In India, this issue is under scrutiny and review of National Action Plan for Viral Hepatitis[2],[4],[33].

The Swachh Bharat Mission campaign in India has taken initiatives in maintaining cleanliness and hygiene, setting up of toilets so that open field defecation could be avoided[34]. Awareness generation in different areas of hygiene and sanitation at all levels is carried out under this programme[34],[35]. The National Rural Drinking Water Programme (NRDWP) which ensures safe and potable drinking water for all is also crucial in this regard[34]. Proper implementation of NRDWP and Swachh Bharat Mission will help in this regard. Economic evaluation studies of implementation of hepatitis A and hepatitis E vaccines in National Immunization Schedule should be carried out. Proper regulations for food safety are also required. Ensuring safe food practices everywhere including the street food and hawkers in trains and buses is also important. Role of Municipal Corporations and Gram Panchayat is crucial in this regard. Specific awareness campaign on hepatitis E in pregnancy is to be done. All mother and child care units personnel should be given training on diagnosis and management of hepatitis during pregnancy with special focus on hepatitis E. The research in this area needs to be prioritized for the benefit of general population.

Conflicts of Interest: None.


1Park K. Textbook of preventive & social medicine, 25th ed. India: Banarasidas Bhanot Publishers; 2017. p. 230-2.
2World Health Organization. Regional Office for South-East Asia. WHO: Regional action plan for viral hepatitis in South-East Asia 2016-21. New Delhi: WHO; 2017. p. 6-44.
3Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India 2016; 72 : 204-10.
4Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011; 161 : 15-22.
5Gurley ES, Halder AK, Streatfield PK, Sazzad HM, Huda TM, Hossain MJ, et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: Possible role of hepatitis E infection. Am J Public Health 2012; 102 : 2248-54.
6National Center for Disease Control. NCDC Newsletter 2014; 3 : 1-8.
7Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol 2004; 78 : 4838-46.
8Halliday ML, Kang LY, Zhou TK, Hu MD, Pan QC, Fu TY, et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis 1991; 164 : 852-9.
9Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). J Viral Hepat 2001; 8 : 293-303.
10Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Physician 2015; 61 : 607-8.
11Okamoto H, Takahashi M, Nishizawa T, Fukai K, Muramatsu U, Yoshikawa A. Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem Biophys Res Commun 2001; 289 : 929-36.
12Teo CG. Much meat, much malady: Changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect 2010; 16 : 24-32.
13Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: A potential zoonosis in Denmark. Clin Infect Dis 2008; 47 : 1026-31.
14Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40 : 117-22.
15Renou C, Cadranel JF, Bourlière M, Halfon P, Ouzan D, Rifflet H, et al. Possible zoonotic transmission of hepatitis E from pet pig to its owner. Emerg Infect Dis 2007; 13 : 1094-6.
16Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: Understanding the pathogenesis. Liver Int 2008; 28 : 1190-9.
17Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 2009; 16 : 519-23.
18Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999; 58 : 215-20.
19Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001; 100 : 9-15.
20Kumar A, Saraswat VA. Hepatitis E and acute-on-chronic liver failure. J Clin ExpHepatol 2013; 3 : 225-30.
21Ahmed A, Ali IA, Ghazal H, Fazili J, Nusrat S. Mystery of hepatitis E virus: recent advances in its diagnosis and management. Int J Hepatol 2015; 2015 : 1-6.
22Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367 : 1237-44.
23Arankalle V, Mitra M, Bhave S, Ghosh A, Balasubramanian S, Chatterjee S, et al. Changing epidemiology of Hepatitis A virus in Indian children. Vaccine: Development and Therapy 2014; 4 : 7-13.
24Rakesh PS, Sherin D, Sankar H, Shaji M, Subhagan S, Salila S. Investigating a community-wide outbreak of Hepatitis A in India. J Glob Infect Dis 2014; 6 : 59-64.
25Wu WC, Su CW, Yang JY, Lin SF, Chen JY, Wu JC. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area. J Med Virol 2014; 86 : 720-8.
26Dutta AK, Aggarwal A, Kapoor AK, Ray GN, Batra S. Seroepidemiology of hepatitis A in Delhi. Indian J Pediatr 2000; 67 : 77-9.
27Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005; 11 : 1958-60.
28Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362 : 371-3.
29Jia Z, Yi Y, Liu J, Cao J, Zhang Y, Tian R, et al. Epidemiology of hepatitis E virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006. PLoS One 2014; 9 : e110837.
30Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, et al. Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh. Am J Trop Med Hyg 2009; 81 : 875-81.
31Vivek R, Chandy GM, Brown DW, Kang G. Seroprevalence of IgG antibodies to hepatitis E in urban and rural Southern India. Trans R Soc Trop Med Hyg 2010; 104 : 307-8.
32Kotwal A, Singh H, Verma AK, Gupta RM, Jain S, Sinha S, et al. A study of hepatitis A and E virus seropositivity profile amongst young healthy adults in India. Med J Armed Forces India 2014; 70 : 225-9.
33Ministry of Health & Family Welfare, Government of India. Integrated initiative for prevention and control of viral hepatitis: Operational guidelines, July 2018. Available from:, accessed on February 22, 2019.
34Ministry of Drinking Water & Sanitation, Government of India. Guidelines for Swachh Bharat Mission (Gramin). Available from:, accessed on Feburary 22, 2019.
35Alexander K, Allton C, Felsman C, Hahn M, Okegbe T, Palmer D,et al. Ending open defecation in India: Insights on implementation and behavior change for Swachh Bharat Abhiyan. Available from: _2.25.2016.pdf, accessed on June 25, 2018.